Sex differences in the course of schizophrenia across diverse regions of the world
Diego Novick,1 William Montgomery,2 Tamas Treuer,3 Maria Victoria Moneta,4 Josep Maria Haro4 1Eli Lilly and Company, Windlesham, Surrey, UK; 2Eli Lilly Australia Pty Ltd, West Ryde, NSW, Australia; 3Eli Lilly and Company, Neuroscience Research, Budapest, Hungary; 4Parc Sanitari Sant Joan de D&e...
Enregistré dans:
Auteurs principaux: | Novick D, Montgomery W, Treuer T, Moneta MV, Haro JM |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2016
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/31853c122c8e4fdf878927e63784e87a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Perceived stress, quality of life, and coping skills among patients with schizophrenia in symptomatic remission
par: Sheikh Shoib, et autres
Publié: (2021) -
Duration Mismatch Negativity Predicts Remission in First-Episode Schizophrenia Patients
par: Suguru Nakajima, et autres
Publié: (2021) -
Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review
par: Karson C, et autres
Publié: (2016) -
Long-Acting Injectable Drugs in the Maintenance Therapy of Patients with Schizophrenia
par: Natalia N. Petrova, et autres
Publié: (2020) -
Psychosocial Effects of the COVID-19 Pandemic on Patients With Schizophrenia and Their Caregivers
par: Alejandra Caqueo-Urízar, et autres
Publié: (2021)